DOW vs LSTA · P/E 74, rev $39.97B vs $31.7M cap
Dow Inc (DOW) versus Lisata Therapeutics Inc. (LSTA) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Lisata Therapeutics Inc. (LSTA) is a biotechnology company listed on US.
Latest reported DOW revenue for 2025-12-31 was $39.97B. Net income was -$2.44B. Revenue was down 7.0% from 2024-12-31 to 2025-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Latest reported LSTA revenue for 2026-06-30 was $0. Net income was -$7.4M. LSTA currently screens at market cap $31.7M.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. LSTA currently screens at market cap $31.7M.
Not investment advice. Open the DOW and LSTA stock pages for the full models.
Not investment advice.